FDA Inspection 902592 — Purdue Pharma L.P.
The FDA completed an inspection of Purdue Pharma L.P. on Nov 6, 2014 in Cranbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 6, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cranbury, NJ (United States)